Science 37 launches CRO program for decentralized clinical trials

By The Science Advisory Board staff writers

January 21, 2021 -- Science 37 has launched a partnership program called Science 37 Certified, which is designed to empower contract research organizations (CROs) with access, training, and commercial support required to deliver decentralized clinical studies for pharmaceutical sponsors.

The program leverages Science 37's operating system to address the expanding decentralized clinical trial market. As part of the program, CROs will be trained on Science 37's Decentralized Clinical Trial Operating System and will have access to the company's Metasite or virtual study arm for any study they are working on. CROs can also access Science 37's decentralized clinical trial investigator network, in-house mobile nurse capability, top-tier patient recruitment strategies, and consulting services.

"As the clinical trial model becomes more dependent on decentralized methodologies to connect patients and providers, many CROs need to rapidly bolster their operations accordingly to compete," said David Coman, CEO of Science 37. "As the leader in decentralized clinical trials, we've built the most advanced operating system of technology and services to enable decentralization. Now we've made it easy for CROs to plug into our operating system for a more complete value proposition."

Bioclinica debuts AI redaction tool for clinical trials
Bioclinica has launched an artificial intelligence (AI) tool that redacts personal patient information in PDF, video, and photo files from clinical trial...
How is the pharma-AI partnership landscape changing?
Artificial intelligence (AI) is taking on a growing role in drug discovery and development, with some 250 firms in a market space that's worth over $9 billion....
Bioclinica acquires clinical trial AI firm
Clinical trial management services firm Bioclinica has acquired Saliency, the developer of an artificial intelligence (AI)-based software that speeds...
Q2, Adaptive partner for clinical trial services
Q2 Solutions has announced a partnership with Adaptive Biotechnologies to use Adaptive's products in its clinical trial laboratory services.

Copyright © 2021

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter